Skip to main content
. 2020 May 18;16(5):e1008582. doi: 10.1371/journal.ppat.1008582

Fig 4. Mutation of a putative catalytic cysteine residue or deletion of the ankyrin-repeat domain abolishes TGN dispersal by SS-RARP2.

Fig 4

R. rickettsii Iowa expressing SS-RARP2 carrying a mutation of the putative catalytic cysteine at position 109 to an alanine (SS-RARP2-C109A); R. rickettsii Iowa expressing SS-RARP2 with the ankyrin-repeat domain deleted (SS-RARP2ΔAnk); R. rickettsii Iowa expressing SS-RARP2 (SS-RARP2) were used to infect Vero cells. Cultures were fixed at 48 hpi and stained for TGN46 (red) and R. rickettsii (green). Bar = 10 μm.